cagrilintide dosage with tirzepatide Cagrilintide: Benefits, Dosage, and Weight-Loss Potential Explained Cagrilintide and tirzepatide are NOT
Description
Study Design We identified 1 double-blinded RCT (SUSTAIN FORTE) published in 2021
[26] The medications immunosuppressive properties may result from inhibition of T-cell proliferation and activation, as well as reduced antibody production by B-lymphocytes
2021 Jul 17;398(10296):212]
This is currently available as three 2.4 mg injections, taken weekly, rather than a single jab
Do not overlap injections to avoid adverse reactions
For weight management, Zepbound is indicated for adults with a BMI 30 kg/m or 27 kg/m with at least one weight-related comorbid condition
